Recent articles
2 Stocks That Could Skyrocket Over the Chinese Coronavirus Threat
Investors are bidding up these biotechs in response to the health threat.
Aurora Cannabis Still Isn't a Bargain
Aurora's stock is simply too risky to own at this critical juncture.
Is Aphria Stock a Strong Buy Right Now?
Aphria's stock may be one of the few worthwhile buys in the volatile cannabis industry.
Why Inovio Pharmaceuticals Stock Bolted Higher Today
Inovio was awarded a $9 million grant to develop a vaccine against the emerging coronavirus threat.
2 Dividend-Paying Biotech Stocks Worth Owning in 2020
Dividend investors may want to strongly consider buying AbbVie and Gilead Sciences right now.
Why Novavax Shares Are Jumping Today
The vaccine maker's stock is getting a lift from a pair of catalysts this morning.
2 Ultra-Expensive Biotech Stocks Still Worth Buying
BeiGene and Vertex Pharmaceuticals aren't nearly as expensive as you may think.
2 Small-Cap Biotech Stocks to Watch in 2020
HOOKIPA Pharma and Viking Therapeutics could catch first at some point this year. Here's why.
2 Mid-Cap Biotech Stocks to Buy Right Now
Amarin and Intercept Pharmaceuticals could trounce the broader markets this year.
Can Catalyst Pharmaceuticals Stock Rebound in 2020?
Catalyst appears poised for a strong 2020.
Does Geron Corporation Stock Belong in Your Portfolio in 2020?
Geron has a long road ahead. Is this speculative biotech stock worth the wait?
Up 71%, Is Novavax Stock Still a Strong Buy?
The outbreak of a deadly respiratory virus caused Novavax's shares to take flight yesterday. Can the biotech's stock climb even higher, or is it time to take profits?
3 Top Biotech Picks for 2020
These stocks could thump the broader markets this year.
Why Dynavax Technologies Corporation Stock Cratered in 2019
Can Dynavax's stock rebound after a dreadful 2019?
Why Pfizer Stock Fell 10.2% in 2019
The drugmaker's planned metamorphosis failed to impress investors, but that wasn't its only headwind.
2 Best Cannabis Stocks to Own in 2020
Canopy Growth and Cronos Group are in a class of their own among legal pot plays.
Why Biogen Stock Slumped Last Year
Biogen's decision to forgo a major deal weighed on its shares in 2019.
Why AbbVie Stock Dipped in 2019
AbbVie's shares had an off year in 2019. Here's why.
Better Buy: Biogen vs. Gilead Sciences
Which of these two biotech giants is the better buy in 2020?
Is HEXO Stock a Buy?
The Canadian cannabis grower and distributor had a dreadful 2019 that sent its shares tumbling to levels that could be tempting for bargain hunters.